Keyphrases
Porcine Model
100%
Myopic Choroidal Neovascularization (mCNV)
90%
Multifocal Electroretinogram (mfERG)
77%
Retinal pigment Epithelium
63%
Risk Factors
63%
Endophthalmitis
61%
Subretinal
56%
Retinopathy of Prematurity
56%
Oxygen Tension
56%
Age-related Maculopathy
56%
Cataract Surgery
53%
Optic Nerve
52%
Carbonic Anhydrase Inhibitors
49%
Denmark
45%
Retina
45%
Visual Acuity
44%
Porcine
42%
Glial Cell Line-derived Neurotrophic Factor
42%
Pathological Findings
42%
Copenhagen
42%
Rhegmatogenous Retinal Detachment
42%
Face-down Positioning
42%
Dorzolamide
38%
Vitrectomy
38%
Retinal Function
36%
Macular Volume
35%
Fellow Eye
34%
Optical Coherence Tomography
34%
Age-related Macular Degeneration
33%
Best-corrected Visual Acuity
33%
Macular Surgery
32%
Intravitreal Injection
32%
Visual Impairment
30%
Retinal Detachment
29%
After Cataract
29%
Acute Retinal Ischemia
29%
Bruch's Membrane
29%
Intraocular Pressure
28%
Branch Retinal Vein Occlusion
28%
Pig Model
28%
Visual Outcome
28%
Neovascular Age-related Macular Degeneration (nAMD)
28%
Intravitreal Ranibizumab
28%
Diabetic Macular Edema
28%
Retinal Artery
25%
Retinal Vessels
24%
Retinal Damage
23%
Intravitreal
23%
Fundus Photography
23%
Cataract
21%
Medicine and Dentistry
Cataract Surgery
96%
Visual Acuity
78%
Macular Hole
77%
Endophthalmitis
70%
Vitrectomy
66%
Choroidal Neovascularization
63%
Retinal Detachment
61%
Visual Impairment
61%
Optic Nerve
56%
Intravitreal Administration
51%
Epiretinal Membrane
45%
Electroretinography
44%
Retinal Blood Vessel
43%
Cataract
42%
Branch Retinal Vein Occlusion
42%
Retinopathy of Prematurity
42%
Cohort Effect
39%
Optical Coherence Tomography
39%
Dorzolamide
37%
Fundus Photography
37%
Randomized Clinical Trial
37%
Vitreous
36%
Best Corrected Visual Acuity
35%
Silicone Oil
32%
Bruch's Membrane
32%
Indocyanine Green
32%
Retinal Pigment Epithelium
32%
Prevalence
30%
Photoreceptor
29%
Retina Injury
29%
Visual Pigment
28%
Diabetic Macular Edema
28%
Ophthalmology
26%
Age Related Macular Degeneration
23%
Placebo
23%
Surgeon
22%
Randomized Controlled Trial
22%
Postoperative Complication
21%
Diabetic Retinopathy
21%
Diabetes
20%
Histopathology
20%
Glaucoma
18%
Disease Management
18%
Morphology
18%
Epithelial Cell
16%
Programmed Cell Death
16%
Reoperation
16%
Prognostic Factor
15%
Fluorescein
15%
Indometacin
15%